🇺🇸 FOLFOX regimen in United States

30 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Malignant Neoplasm Progression — 5 reports (16.67%)
  2. Neoplasm Malignant — 5 reports (16.67%)
  3. Diarrhoea — 4 reports (13.33%)
  4. Death — 3 reports (10%)
  5. Palmar-Plantar Erythrodysaesthesia Syndrome — 3 reports (10%)
  6. Anaemia — 2 reports (6.67%)
  7. Disease Progression — 2 reports (6.67%)
  8. Flushing — 2 reports (6.67%)
  9. Leukopenia — 2 reports (6.67%)
  10. Mucosal Inflammation — 2 reports (6.67%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is FOLFOX regimen approved in United States?

FOLFOX regimen does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for FOLFOX regimen in United States?

MIPO Clinic is the originator. The local marketing authorisation holder may differ — check the official source linked above.